Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

[61-Year-Old Patient with Isolated Pleural Effusion].

Muehlenberg K, Federle C, Pech O.

Dtsch Med Wochenschr. 2019 Aug;144(17):1185-1186. doi: 10.1055/a-0862-8155. Epub 2019 Aug 27. German. No abstract available.

PMID:
31454839
2.

Inventories of naive and tolerant mouse CD4 T cell repertoires reveal a hierarchy of deleted and diverted T cell receptors.

Hassler T, Urmann E, Teschner S, Federle C, Dileepan T, Schober K, Jenkins MK, Busch DH, Hinterberger M, Klein L.

Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18537-18543. doi: 10.1073/pnas.1907615116. Epub 2019 Aug 26.

3.

Epitope-Specific Tolerance Modes Differentially Specify Susceptibility to Proteolipid Protein-Induced Experimental Autoimmune Encephalomyelitis.

Wang L, Winnewisser J, Federle C, Jessberger G, Nave KA, Werner HB, Kyewski B, Klein L, Hinterberger M.

Front Immunol. 2017 Nov 9;8:1511. doi: 10.3389/fimmu.2017.01511. eCollection 2017.

4.

Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83.

von Rohrscheidt J, Petrozziello E, Nedjic J, Federle C, Krzyzak L, Ploegh HL, Ishido S, Steinkasserer A, Klein L.

J Exp Med. 2016 Aug 22;213(9):1685-94. doi: 10.1084/jem.20160316. Epub 2016 Aug 8.

5.

TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.

Hauer J, Püschner S, Ramakrishnan P, Simon U, Bongers M, Federle C, Engelmann H.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2874-9. Epub 2005 Feb 11.

6.

M-DC8+ leukocytes--a novel human dendritic cell population.

Schäkel K, Poppe C, Mayer E, Federle C, Riethmüller G, Rieber EP.

Pathobiology. 1999;67(5-6):287-90.

PMID:
10725804
7.
8.

Structural diversity of monoclonal CD4 antibodies and their capacity to block the HIV gp120/CD4 interaction.

Weissenhorn W, Chen YH, Reiter C, Federle C, Weiss EH, Riethmüller G, Rieber EP.

Hybridoma. 1996 Apr;15(2):117-24.

PMID:
8743291
9.

Recombinant CD4-IgE, a novel hybrid molecule, inducing basophils to respond to human immunodeficiency virus (HIV) and HIV-infected target cells.

Krauss S, Kufer P, Federle C, Tabaszewski P, Weiss E, Rieber EP, Riethmüller G.

Eur J Immunol. 1995 Jan;25(1):192-9.

PMID:
7531144
10.

[Involvement of the lungs in neurofibromatosis].

Mitlehner W, Federle C, Höhne U, Finck GA.

Dtsch Med Wochenschr. 1993 Dec 10;118(49):1797-802. German.

PMID:
8253042
11.

The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.

Rieber EP, Federle C, Reiter C, Krauss S, Gürtler L, Eberle J, Deinhardt F, Riethmüller G.

Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10792-6.

12.

Pharmacokinetic and pharmacodynamic studies in man simulating acute and chronic treatment with oral pirenzepine.

Londong W, Londong V, Federle C, Tanswell P, Voderholzer U.

Eur J Clin Pharmacol. 1989;36(4):369-74.

PMID:
2737229

Supplemental Content

Loading ...
Support Center